Market Scenario

Global Research Antibodies Market was valued US$ 105Bn in 2017 and is anticipated to reach US$ 9.34Bn by 2026 at a CAGR of about 7.06% during a forecast.

Global Research Antibodies Market scope is divided by Product type, by Antibody Clonality, by Antibody Source, by Technology, by Application, by End User and by region. Based on Product Type Research Antibodies Market is segmented into Primary & Secondary. By Antibody Clonality are segmented in Monoclonal antibody, Polyclonal antibody & Oligo clonal antibody. By Antibody Source are segmented in Mouse, Rabbit & Others, By Technology are segmented in to Western Blotting, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Immunofluorescence, Immunoprecipitation & Others. By Application are segmented in Infectious Diseases, Immunology, Oncology, Stem Cells, neurobiology & others. By End User are segmented in Pharmaceutical & Biotechnological Companies, Academic & Research Institutes & Contract Research Organizations. Geographically into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Global Research Antibodies Market

The driving factors for the Research Antibodies Market are Increasing Research and development activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, increasing prevalence of cancer and other chronic diseases with increasing healthcare expenditure, growing population, increasing urbanization & industrialization and various government authorities are supporting this R&D growth by providing funding and reducing approval time for new drug molecules.
Poor quality products offered by local vendors and investment of huge money and time in the antibody development process can hamper the growth of Research Antibodies Market.

In terms of Antibody Clonality, Monoclonal antibody segment are in leading share of the market in forecast period. Monoclonal antibodies are cheaper to develop than conventional drugs because it is based on tested technology, Side effects can be treated and reduced by using mice-human hybrid cells or by using fractions of antibodies and most useful for bind to specific diseased or damaged cells needing treatment are factor for growth in market. In Technology, Western blotting is segment accounted for the largest share of the research antibodies market. One of the biggest in favour of western blot is its sensitivity and its ability to detect as little as 0.1 mammograms of protein in a sample, the technique can theoretically serve as an effective early diagnostic tool, sensing even the slightest immunogenic response from a virus or bacteria in a patient sample and widely used in research activities conducted by academic institutes as well as pharmaceutical and biotechnology companies.

In terms of application segment, proteomics will hold the largest market during the forecast period. The upsurge in proteomics research is attributed to the rising need for designing more effective drugs through protein based disease profiling, growing demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomics research. In end User, Pharmaceutical & Biotechnological Companies held the largest market share in 2016. Market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.

Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. This regional segment shows significant market growth opportunities owing to proteomics and genomics research & increasing research funding, rising economics, rising population, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.

Abcam PLC, Active Motif, Affinity Biologicals Inc., Becton Dickinson and Company, Bethyl Laboratories Inc., Biolegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Danaher Corporation, Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd, Genscript, Jackson Immunoresearch Inc., Lonza, Merck Group, Miltenyl Biotec, Origene Technologies Inc., Perkinelmer Inc., Qiagen N.V., Rockland Immunochemicals Inc., Sysmex Corporation, Thermo Fisher Scientific Inc.
Scope of the Global Research Antibodies Market:

Global Research Antibodies Market: By Product Type

• Primary
• Secondary
Global Research Antibodies Market: By Antibody Clonality

• Monoclonal antibody
• Polyclonal antibody
• Oligo clonal antibody
Global Research Antibodies Market: By Antibody Source

• Mouse
• Rabbit
• Others
Global Research Antibodies Market: By Technology

• Western Blotting
• Flow Cytometry
• Enzyme-linked Immunosorbent Assay
• Immunohistochemistry
• Immunofluorescence
• Immunoprecipitation
• Others
Global Research Antibodies Market: By Application

• Proteomics
• Infectious Diseases
• Immunology
• Oncology
• Stem Cells
• Neurobiology
• Others
Global Research Antibodies Market: By End User

• Pharmaceutical & Biotechnological Companies
• Academic & Research Institutes
• Contract Research Organizations
Global Research Antibodies Market: By region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Player analysed in the Global Research Antibodies Market:

• Abcam PLC
• Active Motif
• Affinity Biologicals Inc.
• Becton Dickinson and Company
• Bethyl Laboratories Inc.
• Biolegend Inc.
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Danaher Corporation
• Enzo Life Sciences Inc.
• F. Hoffmann-La Roche Ltd
• Genscript
• Jackson Immunoresearch Inc.
• Lonza
• Merck Group
• Miltenyl Biotec
• Origene Technologies Inc.
• Perkinelmer Inc.
• Qiagen N.V.
• Rockland Immunochemicals Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.